Continuously improving ifosfamide/mesna: a winning combination.
Anderson
Peter
P
Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. pmanders@mdanderson.org
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage* / Q000009:adverse effects; D015080:Mesna / Q000008:administration & dosage* / Q000009:adverse effects; D012509:Sarcoma / Q000188:drug therapy*
D015080:Mesna; D007069:Ifosfamide